Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Falk

Showing results (491-500 of 580) with videos related to

Pageof 58
Sort By:
Gynecologic Oncology|March 14, 2024
Corrigendum to "Self-reported lower extremity lymphedema and quality of life after surgical staging of endometrial carcinoma: A population based cross-sectional study" [Gynecologic Oncology 175 (2023) 72-80]Pernille K Bjerre Trent, Nina Jebens Nordskar, Knut R Wangen, et al.
Gynecologic Oncology|June 16, 2023
Self-reported lower extremity lymphedema and quality of life after surgical staging of endometrial carcinoma: A population based cross-sectional studyPernille K Bjerre Trent, Nina Jebens Nordskar, Knut R Wangen, et al.
Plos One|June 9, 2017
Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitisRichard Taubert, Matthias Hardtke-Wolenski, Fatih Noyan, et al.
Cancer Chemotherapy and Pharmacology|April 10, 2008
A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinomaL C Scott, J C Yao, A B Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2015
Heart Failure and Asymptomatic Left Ventricular Systolic Dysfunction in Lymphoma Survivors Treated With Autologous Stem-Cell Transplantation: A National Cross-Sectional StudyKlaus Murbraech, Knut B Smeland, Harald Holte, et al.
Frontiers in Immunology|August 30, 2021
Case Report: Convalescent Plasma Therapy Induced Anti-SARS-CoV-2 T Cell Expansion, NK Cell Maturation and Virus Clearance in a B Cell Deficient Patient After CD19 CAR T Cell TherapyBerislav Bošnjak, Ivan Odak, Christiane Ritter, et al.
Frontiers in Molecular Medicine|January 21, 2025
Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse modelCaroline Schoenherr, Stefan Pietzsch, Cristina Barca, et al.
European Journal of Immunology|March 30, 2026
Post-Acute Sequelae Patients with Severe COVID-19 History Show a Prolonged Inflammatory, Vascular Injury PatternLouisa Ruhl, Isabell Pink, Evgeny Chichelnitskiy, et al.
Hepatology (Baltimore, Md.)|December 6, 2014
Autoimmune hepatitis in a murine autoimmune polyendocrine syndrome type 1 model is directed against multiple autoantigensMatthias Hardtke-Wolenski, Richard Taubert, Fatih Noyan, et al.
Frontiers in Immunology|February 12, 2019
Immune Status in Children Before Liver Transplantation-A Cross-Sectional Analysis Within the ChilsSFree Multicentre Cohort StudyTamara Möhring, André Karch, Christine S Falk, et al.
Pageof 58

Showing results (491-500 of 580) with videos related to

Sort By:
Pageof 58
Gynecologic Oncology|March 14, 2024
Corrigendum to "Self-reported lower extremity lymphedema and quality of life after surgical staging of endometrial carcinoma: A population based cross-sectional study" [Gynecologic Oncology 175 (2023) 72-80]Pernille K Bjerre Trent, Nina Jebens Nordskar, Knut R Wangen, et al.
Gynecologic Oncology|June 16, 2023
Self-reported lower extremity lymphedema and quality of life after surgical staging of endometrial carcinoma: A population based cross-sectional studyPernille K Bjerre Trent, Nina Jebens Nordskar, Knut R Wangen, et al.
Plos One|June 9, 2017
Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitisRichard Taubert, Matthias Hardtke-Wolenski, Fatih Noyan, et al.
Cancer Chemotherapy and Pharmacology|April 10, 2008
A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinomaL C Scott, J C Yao, A B Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2015
Heart Failure and Asymptomatic Left Ventricular Systolic Dysfunction in Lymphoma Survivors Treated With Autologous Stem-Cell Transplantation: A National Cross-Sectional StudyKlaus Murbraech, Knut B Smeland, Harald Holte, et al.
Frontiers in Immunology|August 30, 2021
Case Report: Convalescent Plasma Therapy Induced Anti-SARS-CoV-2 T Cell Expansion, NK Cell Maturation and Virus Clearance in a B Cell Deficient Patient After CD19 CAR T Cell TherapyBerislav Bošnjak, Ivan Odak, Christiane Ritter, et al.
Frontiers in Molecular Medicine|January 21, 2025
Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse modelCaroline Schoenherr, Stefan Pietzsch, Cristina Barca, et al.
European Journal of Immunology|March 30, 2026
Post-Acute Sequelae Patients with Severe COVID-19 History Show a Prolonged Inflammatory, Vascular Injury PatternLouisa Ruhl, Isabell Pink, Evgeny Chichelnitskiy, et al.
Hepatology (Baltimore, Md.)|December 6, 2014
Autoimmune hepatitis in a murine autoimmune polyendocrine syndrome type 1 model is directed against multiple autoantigensMatthias Hardtke-Wolenski, Richard Taubert, Fatih Noyan, et al.
Frontiers in Immunology|February 12, 2019
Immune Status in Children Before Liver Transplantation-A Cross-Sectional Analysis Within the ChilsSFree Multicentre Cohort StudyTamara Möhring, André Karch, Christine S Falk, et al.
Pageof 58